Utah has launched a first-in-the-nation pilot program allowing an AI chatbot from Doctronic to renew patient prescriptions, bypassing traditional medical licensing laws via a state regulatory sandbox. The program has sparked intense debate, with Utah's medical licensing board and the American Medical Association calling for a halt due to patient safety risks. While the FDA maintains a hands-off approach to encourage innovation, other states are preparing to follow Utah's lead.
Utah AI prescription refill program
- ▪Utah launched a first-in-the-nation pilot program in January 2026 allowing an AI chatbot called Doctronic to renew patient prescriptions online
- ▪The Doctronic chatbot verifies patient identities, queries a national pharmacy database, and either issues refills or escalates complex requests to telehealth doctors
Medical licensing regulatory authority
- ▪The Doctronic program operates under a Utah regulatory sandbox that permits state officials to waive licensing laws restricting prescribing to licensed medical professionals
- ▪The Cicero Institute, a pro-AI think tank founded by Palantir co-founder Joe Lonsdale, authored the legislative template used by multiple states to license AI medical services
AI safety oversight concerns
- ▪Doctronic's eligible refill list includes roughly 190 medications, though some drugs, including one for irregular heartbeats, were removed due to safety concerns
- ▪Doctronic's program is overseen by a five-member board of AI specialists containing no medical doctors, though human doctors currently review all refill orders
- ▪A non-peer-reviewed study by Doctronic scientists found the AI's diagnoses matched human doctors 80% of the time across 500 telehealth consultations
State regulatory sandbox expansion
- ▪Cicero Institute health policy director Adam Meier stated that pushback against medical AI primarily stems from the economic and workforce fears of healthcare workers
- ▪Texas and Wyoming are waiving rules for AI, while lawmakers in Iowa and Idaho have introduced legislation to formally license AI medical services
Physician medical board opposition
- ▪Eleven members of Utah's medical licensing board signed a letter calling for the pilot program to be halted over patient safety risks
- ▪The American Medical Association opposed automated refills, stating that prescription renewals are not routine checkboxes
- ▪Utah's medical licensing board was not notified of the Doctronic program prior to its public launch in January 2026
FDA federal regulation approach
- ▪The Food and Drug Administration has not authorized any AI chatbots but maintains a hands-off approach to encourage medical innovation
- ▪Doctronic executives consider their AI chatbot to be part of state-regulated medical practice, bypassing federal Food and Drug Administration oversight
Story comments
Loading comments…